FibroGen, Inc. (FGEN)
NASDAQ: FGEN · Real-Time Price · USD
5.35
+0.08 (1.52%)
Jul 2, 2025, 10:16 AM - Market open
FibroGen Employees
FibroGen had 225 employees as of December 31, 2024. The number of employees decreased by 261 or -53.70% compared to the previous year.
Employees
225
Change (1Y)
-261
Growth (1Y)
-53.70%
Revenue / Employee
$31,093
Profits / Employee
-$44,476
Market Cap
21.62M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
FGEN News
- 19 days ago - Adobe, FibroGen And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
- 19 days ago - FibroGen Announces 1-for-25 Reverse Stock Split - GlobeNewsWire
- 22 days ago - FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors - GlobeNewsWire
- 7 weeks ago - FibroGen, Inc. (FGEN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - FibroGen Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 7 weeks ago - Duchenne Muscular Dystrophy (DMD) Pipeline Insight Report 2025, Featuring Analysis of Vamorolone (Santhera), Givinostat (Italfarmaco), and Pamrevlumab (Fibrogen) - GlobeNewsWire
- 2 months ago - FibroGen to Report First Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - FibroGen to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire